Longevity Health Holdings, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Longevity Health Holdings, Inc. (XAGE) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$4.83 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-03-31
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$0.83.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$1.56.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$1.52.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was -$4.13.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$4.83.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$14.96.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$1.53.
- Longevity Health Holdings, Inc. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$5.47.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$4.83 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$0.83 10-Q · filed 2025-11-14 | -$3.68 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | -$1.56 10-Q · filed 2025-08-14 | -$3.08 10-Q · filed 2025-08-14 | ||||||
| 2025-03-31 | -$1.52 10-Q · filed 2025-05-15 | |||||||
| 2024-12-31 | -$14.96 10-K · filed 2026-03-31 | -$0.50 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | -$4.13 10-Q · filed 2025-11-14 | -$0.14 10-Q · filed 2024-11-14 | -$13.58 10-Q · filed 2025-11-14 | -$0.45 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | -$4.78 10-Q · filed 2025-08-14 | -$0.16 10-Q · filed 2024-08-14 | -$9.43 10-Q · filed 2025-08-14 | -$0.31 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$4.65 10-Q · filed 2025-05-15 | -$0.16 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$1.53 10-K/A · filed 2025-06-17 | |||||||
| 2023-09-30 | -$0.49 10-Q · filed 2024-11-14 | -$2.46 10-Q · filed 2024-11-14 | ||||||
| 2023-06-30 | -$5.00 10-Q · filed 2024-08-14 | -$6.89 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$1.91 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | -$5.47 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |